A Study to Evaluate Tolerability of Two Topical Drug Products in the Treatment of Facial Acne

PHASE4CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

July 31, 2009

Primary Completion Date

November 30, 2009

Study Completion Date

November 30, 2009

Conditions
Acne Vulgaris
Interventions
DRUG

Clindamycin and benzoyl peroxide gel (Duac® Topical Gel)

Subjects will apply Duac(clindamycin and benzoyl peroxide) gel to one-half of their face and and apply Epiduo (benzoyl peroxide/adapalene) gel on the other side of their face once a day for the first 2 weeks. Starting at week 2, subjects will apply Duac (benzoyl peroxide/clindamycin gel) to the entire face for an additional 6 weeks.

DRUG

benzoyl peroxide and adapalene gel (EPIDUO™ Gel)

Subjects will apply Duac(clindamycin and benzoyl peroxide) gel to one-half of their face and and apply Epiduo (benzoyl peroxide/adapalene) gel on the other side of their face once a day for the first 2 weeks. Starting at week 2, subjects will apply Duac (benzoyl peroxide/clindamycin gel) to the entire face for an additional 6 weeks.

Trial Locations (2)

20850

Aesthetics, Skin Care & Dermasurgery, Rockville

48088

Grekin Skin Institute, Warren

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

Stiefel, a GSK Company

INDUSTRY

NCT00964223 - A Study to Evaluate Tolerability of Two Topical Drug Products in the Treatment of Facial Acne | Biotech Hunter | Biotech Hunter